This inventor holds 2 USPTO granted patents. Top assignees: Centre National De La Recherche Scientifique, Universitè De Montpellier. Active years: 2012.
Company Filing History:
2 out of 5,383 
2 out of 297 
Years Active: 2012
Title: Mylène Weill: Innovator in Acetylcholinesterase Inhibitors
Introduction
Mylène Weill is a prominent inventor based in Montpellier, France. She has made significant contributions to the field of biochemistry, particularly in the development of acetylcholinesterase inhibitors. With a total of 2 patents, her work has implications for both medical and agricultural applications.
Latest Patents
Mylène Weill's latest patents include innovative uses of compounds derived from pyrimidinetrione as acetylcholinesterase inhibitors. The first patent focuses on the application of these compounds in inhibiting acetylcholinesterase (AChE), which is crucial for various therapeutic uses. The second patent addresses a novel acetylcholinesterase gene (ace-1) that is responsible for resistance to organophosphorus and carbamates in mosquitoes. This gene's discovery is vital for developing new insecticides and for genetic detection of resistance in mosquito populations.
Career Highlights
Throughout her career, Mylène has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université de Montpellier. Her research has not only advanced scientific knowledge but has also paved the way for practical applications in pest control and disease management.
Collaborations
Mylène has collaborated with notable colleagues, including Philippe Fort and Michel Raymond. These partnerships have enriched her research and contributed to her innovative work in the field.
Conclusion
Mylène Weill's contributions to the development of acetylcholinesterase inhibitors highlight her role as a leading inventor in biochemistry. Her patents and collaborations reflect her commitment to advancing science for practical applications.